头部CRO剥离CDMO业务,药明康德、康龙化成是劲敌?

盖德视界
Feb 27

中国CRO直接在“家门口”抢生意。又一家头部CRO战略聚焦,抛售非核心业务Guide View查尔斯河实验室(Charles River Laboratories,代码:CRL)在去年11月承诺出售7%的业务后,现已兑现承诺。2月25日,这家年营收超40亿美元的海外头部CRO企业宣布,已签署最终协议,将在单独的交易中出售某些欧洲发现服务资产以及CDMO和细胞解决方案业务——CDMO 业务将转移给 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10